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An elderly patient, with a history of depression with psychosis, presented with breathlessness, a right
exudative pleural effusion and a peripheral eosinophilia. The pleural ﬂuid was eosinophil-rich (10% of
leucocytes). Olanzapine therapy had been commenced 12 months previously. There was a family history
of TB and the patient was of African origin. A full diagnostic work-up ensued including computed to-
mography of the thorax and local anaesthetic thoracoscopy. The pleura was unremarkable on CT and
displayed bland smooth thickening at visual inspection during thoracoscopy. Pleural biopsies demon-
strated chronic inﬂammation with eosinophils but no evidence of granulomatous inﬂammation or ma-
lignancy. Pleural tissue culture did not yield mycobacteria. A diagnosis of olanzapine-induced
eosinophilic pleuritis was suspected and the pleural disease resolved with withdrawal of olanzapine.
Eosinophilic pleural ﬂuid is not a marker of non-malignant aetiology and eosinophilic pleural effusions
require a careful and systematic diagnostic work-up. This is the second case report to identify olanzapine
as a causative agent in eosinophilic pleural effusion.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Case report
An elderly patient presented with progressive breathlessness
and a dull ache in the lateral right chest wall. Past medical history
included cerebrovascular disease and recurrent depression with
psychosis. 12 months previously treatment with olanzapine had
been commenced and the dose progressively titrated. The patient
was born in Africa and had lived in the United Kingdom (UK) for
several decades. Occupational history revealed no relevant expo-
sures. The patient was a lifelong non-smoker. There was a family
history of tuberculosis. The patient wasWHO performance status 2.
Examination revealed reduced breath sounds and dullness to per-
cussion in the right chest, conﬁrmed as a pleural effusion on chest
X-ray (CXR). This effusion was not present on CXR two years pre-
viously (Fig. 1). Routine laboratory blood tests revealed a peripheral
eosinophilia (1.27  109/L). Pleural aspiration was undertaken andUniversity Hospital of South
, UK. Tel.: þ44 161 291 2721;
, matthew.evison@uhsm.nhs.
Ltd. This is an open access article ubiochemical analysis classiﬁed the effusion as an exudate (ﬂuid
protein 56 g/L, serum protein 82 g/L, ﬂuid LDH 522 U/L and serum
LDH 385 U/L). However there was no bacterial or mycobacterial
growth on culture. Fluid cytology revealed an excess of eosinophils
(10% of leucocytes) and reactive mesothelial cells. Computed To-
mography (CT) of the thorax demonstrated a moderate-sized uni-
lateral pleural effusion with an unremarkable appearance of the
pleura, including no mediastinal pleural thickening. There was,
however, a calciﬁed granuloma in the left lower lobe. A differential
diagnosis of tuberculous pleuritis, malignancy or drug-induced
pleuritis was made and the patient underwent local anaesthetic
thoracoscopy (Figs. 2e4).
Visual inspection of the pleura revealed bland, smooth pleural
thickening without nodularity or plaques. Pleural biopsy demon-
strated mesothelial proliferation and chronic inﬂammation with
eosinophils. There was no evidence of granulomatous inﬂamma-
tion or malignancy. Pleural tissue sent for culture failed to yield any
growth of mycobacteria. A diagnosis of olanzapine-induced eosin-
ophilic pleuritis was made with subsequent withdrawal of the
medication. The pleural ﬂuid did not re-accumulate following
thoracoscopy and the CXR 6 months later revealed no evidence of
pleural disease.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. CXR series: (A) CXR 2 years prior to presentation and prior to olanzapine therapy, (B) CXR at presentation, (C) CXR 6 months after olanzapine withdrawal.
Fig. 2. Computed tomography of the thorax demonstrating a small to moderate right sided pleural effusion with unremarkable pleura, and a left lower lobe calciﬁed granuloma.
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In the largest single centre cohort analysis of patients with
pleural effusions 7% (135/1868) were classiﬁed as eosinophilic
pleural effusions, deﬁned as 10% eosinophils [1]. Within this
cohort of eosinophilic pleural effusions an underlying cause was
found in 85%. The commonest identiﬁed causes were malignancy
(35%), infection (20%) and chest wall trauma (12%). An eosinophilic
effusion is not, therefore, a marker of non-malignant aetiology.
Interesting, the risk of malignancy seems to be inversely propor-
tional to the percentage of eosinophils both in the study described
above by Krenke et al. and in meta-analysis [1,2].Fig. 3. Papanicolaou stained cytospin demonstrating eosinophil-rich pleural ﬂuid
(cells with bi-lobed nuclei with brown granules). An eosinophilic effusion is deﬁned as
10% eosinophils. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)Drug-induced pleural effusions are an additional cause of
eosinophilic pleural effusions and, given the simple intervention of
drug withdrawal will lead to resolution in the majority of cases, an
important aetiology to consider in all pleural effusions. Our
knowledge of drug-induced eosinophilic pleural effusions stems
almost entirely from case reports [3]. Neurological agents (sodium
valproate, clozapine, dantrolene and ﬂuoxetine), cardiological
agents (warfarin, diltiazem, simvastatin) and antibiotics (nitro-
furantoin) have all been implicated [3]. There has been only one
previous report of olanzapine-induced eosinophilic pleural effusion
[4] and one case involving combined therapy with clozapine and
olanzapine [5].Fig. 4. Pleural biopsy taken during pleuroscopy demonstrating a chronic inﬂammatory
cell inﬁltrate and eosinophils.
M. Evison et al. / Respiratory Medicine Case Reports 14 (2015) 24e2626In conclusion, eosinophilic pleural effusions require a systematic
diagnostic work-up as per non-eosinophilic pleural effusions. They
are not a marker of non-malignant aetiology. A careful medication
history is vital in all patients with pleural disease. This is the second
case to report olanzapine as the causative agent of eosinophilic
pleuritis. Resolution of the pleural disease occurred with discon-
tinuation of the medication.
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